Andrea Lobo,  —

Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.

Articles by Andrea Lobo

Remote monitoring program may help reduce hospital readmissions

Biofourmis and Beacon Health System have partnered for an in-home monitoring program specifically meant for patients with complex chronic diseases, including chronic obstructive pulmonary disease (COPD), during their post-discharge period. Patient-reported data will be automatically collected, analyzed, and presented in a continuously updated dashboard visible to clinicians.

Signify Health Offering At-home Spirometry Test to Diagnose COPD

Signify Health, a U.S. healthcare platform, has added spirometry testing for chronic obstructive lung disease (COPD) to its in-home diagnostic and preventive services. The company began offering spirometry testing in select locations earlier this year, with at-home evaluations available to Medicare Advantage and Medicaid plan members. “In-home…

AeroRx, HCmed Team Up on New Combo of Bronchodilators for COPD

AeroRx Therapeutics is teaming up with HCmed Innovations to develop a new therapeutic combination of different classes of bronchodilators — medications that help open up the airways, making breathing easier — for the treatment of people with chronic obstructive pulmonary disease (COPD). The new combo would be delivered using…